rs116840823
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PM4PP3PP5
The NM_000166.6(GJB1):c.572_580del(p.Thr191_Phe193del) variant causes a inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000913 in 1,095,115 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: not found (cov: 21)
Exomes 𝑓: 9.1e-7 ( 0 hom. 0 hem. )
Consequence
GJB1
NM_000166.6 inframe_deletion
NM_000166.6 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.32
Genes affected
GJB1 (HGNC:4283): (gap junction protein beta 1) This gene encodes a member of the gap junction protein family. The gap junction proteins are membrane-spanning proteins that assemble to form gap junction channels that facilitate the transfer of ions and small molecules between cells. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene cause X-linked Charcot-Marie-Tooth disease, an inherited peripheral neuropathy. Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PM1
In a chain Gap junction beta-1 protein (size 282) in uniprot entity CXB1_HUMAN there are 4 pathogenic changes around while only 0 benign (100%) in NM_000166.6
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_000166.6.
PP3
No computational evidence supports a deleterious effect, but strongly conserved according to phyloP
PP5
Variant X-71224268-AACCGTCTTC-A is Pathogenic according to our data. Variant chrX-71224268-AACCGTCTTC-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 406229.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=1, Uncertain_significance=2}. Variant chrX-71224268-AACCGTCTTC-A is described in Lovd as [Pathogenic]. Variant chrX-71224268-AACCGTCTTC-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GJB1 | NM_000166.6 | c.572_580del | p.Thr191_Phe193del | inframe_deletion | 2/2 | ENST00000361726.7 | NP_000157.1 | |
GJB1 | NM_001097642.3 | c.572_580del | p.Thr191_Phe193del | inframe_deletion | 2/2 | NP_001091111.1 | ||
GJB1 | XM_011530907.3 | c.572_580del | p.Thr191_Phe193del | inframe_deletion | 2/2 | XP_011529209.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GJB1 | ENST00000361726.7 | c.572_580del | p.Thr191_Phe193del | inframe_deletion | 2/2 | 1 | NM_000166.6 | ENSP00000354900 | P1 |
Frequencies
GnomAD3 genomes Cov.: 21
GnomAD3 genomes
Cov.:
21
GnomAD4 exome AF: 9.13e-7 AC: 1AN: 1095115Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 361899
GnomAD4 exome
AF:
AC:
1
AN:
1095115
Hom.:
AF XY:
AC XY:
0
AN XY:
361899
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 21
GnomAD4 genome
Cov.:
21
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Charcot-Marie-Tooth Neuropathy X Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 26, 2016 | This sequence change deletes 9 nucleotides from exon 2 of the GJB1 mRNA (c.572_580delCCGTCTTCA). This leads to the deletion of 3 amino acid residues in the GJB1 protein (p.Thr191_Phe193del) but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (ExAC no frequency). This variant has been reported in two individuals affected with Charcot-Marie-Tooth disease (PMID: 9361298, 18379723). This variant is also known as c.573_581delCGTCTTCAT (p.Val192Met194del) in the literature. Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the deleted amino acids is currently unknown. This variant is located in a region of the GJB1 protein where a significant number of previously reported GJB1 missense mutations, deletions, and insertions are found (PMID: 11257785, 19691535, 15574129, 17052905, 9818870, 9361298, 10737979). These observations suggest that alterations within this region may affect protein function, but experiments have not been done to test this possibility. In summary, this variant is a rare deletion that has been observed in affected individuals and overlaps with previously reported Charcot-Marie-Tooth disease variants. This evidence indicates that the variant is pathogenic, but additional data is needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 11, 2023 | Variant summary: GJB1 c.572_580delCCGTCTTCA (p.Thr191_Phe193del) results in an in-frame deletion that is predicted to remove three amino acids from the encoded protein. The variant was absent in 180670 control chromosomes (gnomAD). c.572_580delCCGTCTTCA has been reported in the literature in individuals affected with Charcot-Marie-Tooth disease X-linked dominant 1 (Bone_1997, Panosyan_2017, Record_2023). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. However, other variants involved in the region (Thr191_Phe193), including missense mutations, duplications, deletions, and insertions, were found in patients affected with Charcot-Marie-Tooth disease X-linked dominant 1 in HGMD database, supporting this region is functional important in GJB1 protein. The following publications have been ascertained in the context of this evaluation (PMID: 9361298, 9888385, 28768847, 37284795, 17052905, 18379723). Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. One submitter classified the variant as likely pathogenic, and one submitter classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 17, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at